HUG breakthrough – Towards a personalized vaccine against brain cancer
18.02.2019
Share this article
The HUG, as part of the GAPVAC (Glioma Actively Personalized Vaccine Consortium) consortium financed by the European Union, have reached a breakthrough point in their 20 years research towards a personalized vaccine against brain cancer.